Interventional Cardiologist Intermountain Medical Center
Cardiology
Dr. Joseph B. Muhlestein, MD
|
|
Give Review
Joseph Muhlestein practices Cardiology. He graduated from University of Utah School of Medicine. Joseph Muhlestein is a published physician. He published 49 publications, including: 'Implementation of a computerized cardiovascular information system in a private hospital setting.'
Publications
- Shortened Telomere Length is Associated with Paroxysmal Atrial Fibrillation Among Cardiovascular Patients Enrolled in the Intermountain Heart Collaborative Study.
- Increasing time between first diagnosis of Atrial fibrillation and catheter ablation adversely affects long-term outcomes.
- Usefulness of Left Atrial Appendage Volume as a Predictor of Embolic Stroke in Patients With Atrial Fibrillation.
- Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ...
- Randomized cross-over trial of short-term water-only fasting: Metabolic and cardiovascular consequences.
- Long-term clinical efficacy and risk of catheter ablation for Atrial fibrillation in octogenarians.
- Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
- Warfarin is not needed in low-risk patients following Atrial fibrillation ablation procedures.
- A genomewide scan for early-onset Coronary artery disease in 438 families: the GENECARD Study.
- Femoral arterial puncture management after percutaneous Coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and ...
- Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of Coronary artery disease in improving continued compliance and reduced mortality.
- Prospective study of pathogen burden and risk of Myocardial infarction or death.
- Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe Coronary artery disease.
- Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coron...
- Randomized secondary prevention trial of azithromycin in patients with Coronary artery disease: primary clinical results of the ACADEMIC study.
- Genetics of coronary Heart disease: current knowledge and research principles.
- A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with Coronary artery disease.
- The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with Coronary artery disease.
- Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined Coronary artery disease.
- Antibiotic therapy for treatment of Chlamydia to prevent coronary Heart disease events.
- Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
- Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular Disease.
- The ACADEMIC study in perspective (Azithromycin in Coronary artery disease: elimination of myocardial infection with Chlamydia).
- Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
- Chlamydia pneumoniae in Coronary artery disease.
- Chronic infection and Coronary artery disease.
- Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with Coronary artery disease and myocardial infarction.
- Animal models of chlamydia and atherosclerosis.
- Effect of institutional volume and academic status on outcomes of Coronary interventions: the IMPACT-II experience.
- The ten most commonly asked questions about infection as a cause of atherosclerotic Heart disease.
- Randomized secondary prevention trial of azithromycin in patients with Coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithro...
- Association of lipoprotein lipase gene polymorphisms with Coronary artery disease.
- Infective Endocarditis: how well are we managing our patients?
- Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or Coronary artery disease.
- Implementation of a computerized cardiovascular information system in a private hospital setting.
- Bacterial infections and atherosclerosis.
- Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for Coronary artery disease and myocardial infarction.
- Angiotensin-converting enzyme genotypes and risk for Myocardial infarction in women.
- Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
- A comparison of the accuracy and reproducibility of digital three-dimensional Coronary artery reconstructions using edge detection or videodensitometry.
- "Rescue" utilization of abciximab for the dissolution of Coronary thrombus developing as a complication of Coronary angioplasty.
- Prospective, randomized, multicenter comparison of laser-facilitated balloon angioplasty versus stand-alone balloon angioplasty in patients with obstructive Coronary a...
- A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for Coronary artery disease or myocardial infarction.
- Developing care process models.
- Velocity measurement based on bolus tracking with the aid of three-dimensional reconstruction from digital subtraction angiography.
- Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for Acute myocardial infarction.
- An emergency department-based protocol for rapidly ruling out Myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).
- Increased incidence of Chlamydia species within the Coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.
Schools
University of Texas Southwestern Medical Center At Dallas
University of Utah
Duke University
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Commercial Insurance Company
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Duke University Hospital -
University of Utah School of Medicine
Hospital
-
Intermountain Medical Center
Helpful Reviews
Similar Doctors
|
Dr. John D. Day, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah Budge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Osborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward C. Miner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdallah G. Kfoury, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gary P. Symkoviak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Armond M. Lapine, MD
This Doctor is OpenDoctor Recommended.
|